Loader

Pathways

PathWhiz ID Pathway Meta Data

PW144870

Pw144870 View Pathway
drug action

Tetracycline Drug Metabolism Action Pathway

Homo sapiens

PW146195

Pw146195 View Pathway
drug action

Tetracycline phosphate complex Drug Metabolism Action Pathway

Homo sapiens

PW176235

Pw176235 View Pathway
metabolic

Tetracycline Predicted Metabolism Pathway

Homo sapiens
Metabolites of Tetracycline are predicted with biotransformer.

PW146352

Pw146352 View Pathway
drug action

Tetradecyl hydrogen sulfate (ester) Drug Metabolism Action Pathway

Homo sapiens

PW176538

Pw176538 View Pathway
metabolic

Tetradecyl hydrogen sulfate (ester) Predicted Metabolism Pathway

Homo sapiens
Metabolites of Tetradecyl hydrogen sulfate (ester) are predicted with biotransformer.

PW146835

Pw146835 View Pathway
drug action

Tetraferric tricitrate decahydrate Drug Metabolism Action Pathway

Homo sapiens

PW146991

Pw146991 View Pathway
metabolic

Tetrahydrocannabinol Drug Metabolism Pathway

Homo sapiens

PW002417

Pw002417 View Pathway
metabolic

Tetrahydrofolate Biosynthesis

Saccharomyces cerevisiae
The biosynthesis of tetrahydrofolate begins with guanosine triphosphate interacting with water through GTP-cyclohydrlase resulting in the release of a formic acid, a hydrogen ion and a dihydroneopterin triphosphate. The latter compound then reacts with water in a spontaneous reaction resulting in the release of pyrophosphate, hydrogen ion and dihydroneopterinphosphate. Dihydroneopterin phosphate then reacts spontaneously with water resulting in the release of phosphate and 7,8-dihydroneopterin. This compound reacts wuth a folic acid synthesis enzyme resulting in the release of glycoaldehyde and 6-hydroxymethyl-7,8-dihydropterin. The latter compound is then diphosphorylated through an ATP driven folic acid synthesis resulting in the release of AMP, a hydrogen ion and 6-hydroxymethyl-7,8-dihydropterin diphosphate. This compound reacts with p-Aminobenzoic acid that is release from chorismate, the reaction happens through a folic acid synthesis resulting in the pyrophosphate and 7,8-dihydropteric acid. The latter compound reacts with glutamic acid through an ATP driven folic acid synthesis 3 resulting in the release of hydrogen ion, a phosphate, ADP and a 7,8-dihydrofolate monoglutamate. The latter compound reacts with a hydrogen ion through a NADPH through a dihydrofolate reductase resulting in the release of NADP and tetrahydrofolate. This compound can also be a result of 5,10 methenyltetrahydrofolic acid reacting with water through a mitochondrials c1-tetrahydrofolate synthase which releases a 10-formyltetrahydrofolate. This compound in turn reacts with a 5-phosphoribosyl-N-formylglycinamide through a glycinamide ribotide transformylase resulting in the release of a tetrahydrofolate and a 5'phosphoribosyl-N-fromylglycinamide.

PW123538

Pw123538 View Pathway
metabolic

Tetrahydromonapterin Biosynthesis

Pseudomonas aeruginosa
This pathway demonstrates the biosynthesis of tetrahydromonapterin in E.coli. However, it is still unclear about biological role of tetrahydromonapterin. GTP cyclohydrolase 1 generates formic acid and 7,8-dihydroneopterin 3'-triphosphate with cofactor GTP and water. 7,8-dihydroneopterin 3'-triphosphate is converted to dihydromonapterin-triphosphate by d-erythro-7,8-dihydroneopterin triphosphate epimerase (folX). Later, dihydromonapterin-triphosphate is hydroxylated to dihydromethysticin, and eventually form tetrahydromonapterin via dihydromonapterin reductase (folM) with cofactor NADPH.

PW002043

Pw002043 View Pathway
metabolic

Tetrahydromonapterin Biosynthesis

Escherichia coli
This pathway demonstrates the biosynthesis of tetrahydromonapterin in E.coli. However, it is still unclear about biological role of tetrahydromonapterin. GTP cyclohydrolase 1 generates formic acid and 7,8-dihydroneopterin 3'-triphosphate with cofactor GTP and water. 7,8-dihydroneopterin 3'-triphosphate is converted to dihydromonapterin-triphosphate by d-erythro-7,8-dihydroneopterin triphosphate epimerase (folX). Later, dihydromonapterin-triphosphate is hydroxylated to dihydromethysticin, and eventually form tetrahydromonapterin via dihydromonapterin reductase (folM) with cofactor NADPH.